A detailed history of State Of Wisconsin Investment Board transactions in Harrow Health, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 106,041 shares of HROW stock, worth $4.67 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
106,041
Previous 102,321 3.64%
Holding current value
$4.67 Million
Previous $1.35 Million 63.71%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$10.0 - $21.64 $37,200 - $80,500
3,720 Added 3.64%
106,041 $2.22 Million
Q1 2024

May 14, 2024

BUY
$9.3 - $13.23 $951,585 - $1.35 Million
102,321 New
102,321 $1.35 Million
Q3 2023

Nov 14, 2023

SELL
$14.03 - $22.08 $28,635 - $45,065
-2,041 Reduced 7.72%
24,409 $350,000
Q2 2023

Aug 14, 2023

BUY
$17.37 - $28.08 $459,436 - $742,716
26,450 New
26,450 $503,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $1.19B
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.